Waters and BD’s Biosciences & Diagnostic Solutions to Combine
Waters and BD are merging BD's Biosciences & Diagnostic Solutions unit with Waters in a $17.5 billion Reverse Morris Trust transaction.
Waters and BD are merging BD's Biosciences & Diagnostic Solutions unit with Waters in a $17.5 billion Reverse Morris Trust transaction.
AI-enhanced EEG technology offers a promising, accessible way to detect early signs of Alzheimer’s disease—years before symptoms appear.
A new microneedle-based wearable wristband enables real-time, painless monitoring of glucose, alcohol, lactate, and cardiovascular signals.
SPT Labtech and Semarion have partnered to integrate their respective technologies to streamline and scale adherent cell assay development.
New multidisciplinary guidelines bronchoscopic lung biopsy techniques offer tissue sampling adequacy comparable to other testing methods.